Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP972107priorityCriticalpatent/ECSP972107A/en
Publication of ECSP972107ApublicationCriticalpatent/ECSP972107A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
La presente invención es una composición para estimular los mecanismos de defensa del huésped en un mamífero vía administrar al mamífero una cantidad terapéuticamente efectiva de un interferón vía contacto oromucosal. La cantidad de interferón administrado es menor que la cantidad que induce una respuesta patológica cuando se administra parenteralmente.The present invention is a composition for stimulating host defense mechanisms in a mammal via administering to the mammal a therapeutically effective amount of an interferon via oromucosal contact. The amount of interferon administered is less than the amount that induces a pathological response when administered parenterally.
ECSP9721071997-05-081997-05-08
STIMULATION OF GUEST DEFENSE MECHANISMS AGAINST VIRAL STIMULATIONS
ECSP972107A
(en)
methods of inducing the diuretic effect, inducing, maintaining or restoring the diuretic effect of a non-adenosine modifying diuretic, maintaining, restoring or improving renal function in a patient, inducing diuresis, preventing the onset of renal impairment in a patient with fluid or CHF overload, treating CHF patients and improving overall health outcomes, pharmaceutical composition and uses